{"id":16262,"date":"2013-02-15T01:30:00","date_gmt":"2013-02-15T00:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/spagna-in-2-anni-15-vendite-per-95-aziende\/"},"modified":"2013-02-15T01:30:00","modified_gmt":"2013-02-15T00:30:00","slug":"spagna-in-2-anni-15-vendite-per-95-aziende","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/spagna-in-2-anni-15-vendite-per-95-aziende\/","title":{"rendered":"Spain, in 2 years -15% sales for 95% companies"},"content":{"rendered":"

The 95% of pharmaceutical companies operating in Spain ensures that their sales have decreased by an average of 15% in the last two years, following the government interventions to reduce healthcare costs implemented since 2010. However, companies are still eager to stay on the Iberian market and are implementing a series of strategies that allow them to do so. <\/p>\n

<\/font><\/span><\/p>\n

This is what emerges from a Europa Press survey. As short-medium term measures, the companies aim to restore price margins (86% of the interviewees), to strengthen the regulatory environment (75%) and to reduce costs and infrastructures (56%). Looking longer term, the survey also finds that the 71% of companies are looking to grow through portfolios of better products, with an emphasis on research and development; 58% is seeking to sell its non-strategic subsidiaries; the 54% has plans to increase both pricing and production volume. Finally, the 50% is considering strategic partnerships and joint ventures with a Spanish or multinational partner.<\/p>\n

<\/font><\/span><\/p>\n

According to Business Monitor International reveals that for the full year 2012 pharmaceutical sales in Spain will increase from 20.15 billion euros in 2011 to 18.34 billion.<\/p>\n

<\/font><\/span><\/p>\n

Barbara Di Chiara\u2013 February 15, 2013 \u2013 PharmaKronos<\/font><\/span><\/i><\/p>\n

<\/span><\/p>\n

 <\/p>","protected":false},"excerpt":{"rendered":"

Il 95% delle aziende farmaceutiche che operano in Spagna assicura che le proprie vendite sono diminuite in media del 15% negli ultimi due anni, a seguito degli interventi governativi di riduzione dei costi della sanità operati dal 2010. Tuttavia, le imprese sono ancora desiderose di rimanere sul mercato iberico e stanno attuando una serie di …<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-16262","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/16262","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=16262"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/16262\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=16262"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=16262"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=16262"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}